Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amisulpride Response and Brain Structure in Schizophrenia
NCT02095938Phase 4Unknown
- Sponsor
- CHA University
- Start
- Jan 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of amisulpride in schizophrenia, sponsored by CHA University. Primary endpoint: Brain structures on the structural MRI. Status: unknown.
02
Drugs
amisulpride
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02095938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02095938.